Connor, Clark & Lunn Investment Management (CC&L)’s Standard BioTools LAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-249,944
| Closed | -$980K | – | 1129 |
|
|
2021
Q4 | $980K | Buy |
249,944
+5,828
| +2% | +$22.9K | ﹤0.01% | 682 |
|
|
2021
Q3 | $1.61M | Buy |
244,116
+233,251
| +2,147% | +$1.54M | 0.01% | 560 |
|
|
2021
Q2 | $67K | Sell |
10,865
-138,650
| -93% | -$855K | ﹤0.01% | 950 |
|
|
2021
Q1 | $676K | Sell |
149,515
-143,742
| -49% | -$650K | ﹤0.01% | 754 |
|
|
2020
Q4 | $1.76M | Buy |
293,257
+4,416
| +2% | +$26.5K | 0.01% | 529 |
|
|
2020
Q3 | $2.15M | Buy |
288,841
+166,717
| +137% | +$1.24M | 0.01% | 466 |
|
|
2020
Q2 | $490K | Sell |
122,124
-31,283
| -20% | -$126K | ﹤0.01% | 761 |
|
|
2020
Q1 | $390K | Buy |
+153,407
| New | +$390K | ﹤0.01% | 751 |
|
|
2019
Q3 | – | Sell |
-63,201
| Closed | -$779K | – | 1026 |
|
|
2019
Q2 | $779K | Sell |
63,201
-25,955
| -29% | -$320K | 0.01% | 623 |
|
|
2019
Q1 | $1.19M | Buy |
89,156
+1,224
| +1% | +$16.3K | 0.01% | 497 |
|
|
2018
Q4 | $758K | Sell |
87,932
-92,100
| -51% | -$794K | 0.01% | 608 |
|
|
2018
Q3 | $1.35M | Sell |
180,032
-2,063
| -1% | -$15.4K | 0.01% | 520 |
|
|
2018
Q2 | $1.09M | Sell |
182,095
-6,700
| -4% | -$39.9K | 0.01% | 597 |
|
|
2018
Q1 | $1.1M | Buy |
188,795
+43,950
| +30% | +$257K | 0.01% | 475 |
|
|
2017
Q4 | $853K | Buy |
144,845
+34,519
| +31% | +$203K | 0.01% | 539 |
|
|
2017
Q3 | $556K | Buy |
110,326
+37,201
| +51% | +$187K | ﹤0.01% | 629 |
|
|
2017
Q2 | $295K | Buy |
73,125
+52,625
| +257% | +$212K | ﹤0.01% | 684 |
|
|
2017
Q1 | $117K | Sell |
20,500
-1,600
| -7% | -$9.13K | ﹤0.01% | 841 |
|
|
2016
Q4 | $161K | Sell |
22,100
-35,775
| -62% | -$261K | ﹤0.01% | 811 |
|
|
2016
Q3 | $464K | Buy |
57,875
+11,100
| +24% | +$89K | ﹤0.01% | 593 |
|
|
2016
Q2 | $422K | Sell |
46,775
-2,375
| -5% | -$21.4K | ﹤0.01% | 613 |
|
|
2016
Q1 | $397K | Sell |
49,150
-300
| -0.6% | -$2.42K | ﹤0.01% | 603 |
|
|
2015
Q4 | $535K | Buy |
+49,450
| New | +$535K | ﹤0.01% | 531 |
|